March 6 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely ...

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment is a new chief internal medicine officer. In the role, James List ...

Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine portfolio and will be responsible for advancing the ...

Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

List previously led global therapeutic initiatives at J&J's Janssen unit, emphasizing his background in managing complex drug portfolios. The appointment is part of Pfizer's broader strategy to ...